Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Yue

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Physiological Genomics|December 30, 2004
Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in ratsSek Won Kong, Natalya Bodyak, Patrick Yue, et al.
Peptides|August 22, 2012
In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptakeShiming Xu, Pei Han, Mei Huang, et al.
Circulation. Cardiovascular Quality and Outcomes|September 25, 2014
Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical TrialSuzanne V Arnold, Mikhail Kosiborod, Yan Li, et al.
JAMA Internal Medicine|June 3, 2014
Effects of ranolazine on quality of life among patients with diabetes mellitus and stable anginaSuzanne V Arnold, Mikhail Kosiborod, Darren K McGuire, et al.
Diabetes Care|June 8, 2015
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 DiabetesRobert H Eckel, Robert R Henry, Patrick Yue, et al.
European Journal of Clinical Pharmacology|July 12, 2023
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell diseaseChristina Lourdes Mayer, Kathleen Koeck, Margot Hottmann, et al.
Journal of the American College of Cardiology|July 26, 2014
Reply: In regard to the TERISA trialMikhail Kosiborod, Suzanne V Arnold, John A Spertus, et al.
Journal of the American College of Emergency Physicians Open|March 14, 2022
Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleedingAlexander T Cohen, Megan Lewis, Augusta Connor, et al.
American Heart Journal|September 21, 2015
Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) TrialSuzanne V Arnold, Darren K McGuire, John A Spertus, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 29, 2009
Apelin is necessary for the maintenance of insulin sensitivityPatrick Yue, Hong Jin, Marissa Aillaud, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Physiological Genomics|December 30, 2004
Genetic expression profiles during physiological and pathological cardiac hypertrophy and heart failure in ratsSek Won Kong, Natalya Bodyak, Patrick Yue, et al.
Peptides|August 22, 2012
In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptakeShiming Xu, Pei Han, Mei Huang, et al.
Circulation. Cardiovascular Quality and Outcomes|September 25, 2014
Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical TrialSuzanne V Arnold, Mikhail Kosiborod, Yan Li, et al.
JAMA Internal Medicine|June 3, 2014
Effects of ranolazine on quality of life among patients with diabetes mellitus and stable anginaSuzanne V Arnold, Mikhail Kosiborod, Darren K McGuire, et al.
Diabetes Care|June 8, 2015
Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 DiabetesRobert H Eckel, Robert R Henry, Patrick Yue, et al.
European Journal of Clinical Pharmacology|July 12, 2023
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell diseaseChristina Lourdes Mayer, Kathleen Koeck, Margot Hottmann, et al.
Journal of the American College of Cardiology|July 26, 2014
Reply: In regard to the TERISA trialMikhail Kosiborod, Suzanne V Arnold, John A Spertus, et al.
Journal of the American College of Emergency Physicians Open|March 14, 2022
Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleedingAlexander T Cohen, Megan Lewis, Augusta Connor, et al.
American Heart Journal|September 21, 2015
Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) TrialSuzanne V Arnold, Darren K McGuire, John A Spertus, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 29, 2009
Apelin is necessary for the maintenance of insulin sensitivityPatrick Yue, Hong Jin, Marissa Aillaud, et al.
Pageof 4